Company Description
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities.
It operates through two segments, Infrastructure and Life Sciences.
The company rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts.
It also develops cannabinoid-based products and therapies, such as hemp-based tinctures to treat anxiety, and enhance the lifestyle of patients suffering from Alzheimer's under the Hyalolex brand name; CBD based tinctures, capsules, and topical analgesic creams to treat pain under the Holief brand name; CBD powered beauty and skincare products under the Herbo brand name; and CBD infused beverages under the Sunday Seltzer brand.
The company also engages in the wholesale of hemp extract under the Holi Hemp brand; production of products, such as lotions, creams, and oils, as well as white labeling support services; and extraction and distillation of crude oil into hemp extracts.
It operates in the United States, India, Colombia, and Hong Kong.
The company was incorporated in 2005 and is headquartered in Potomac, Maryland.
Country | United States |
IPO Date | May 24, 2006 |
Industry | Conglomerates |
Sector | Industrials |
Employees | 67 |
CEO | Ram Mukunda |
Contact Details
Address: 10224 Falls Road Potomac, Maryland United States | |
Website | https://www.igcinc.us |
Stock Details
Ticker Symbol | IGC |
Exchange | AMEX |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001326205 |
CUSIP Number | 45408X308 |
ISIN Number | US45408X3089 |
Employer ID | 20-2760393 |
SIC Code | 5065 |
Key Executives
Name | Position |
---|---|
Ram Mukunda | President, Chief Executive Officer & Director |
Benysh Qureshi Esq., M.B.A. | Director of Operations |
Claudia Grimaldi | Vice President, Principal Financial Officer, Chief Compliance Officer & Non-Independent Director |
Rohit Goel | Senior Director of Accounting & Principal Accounting Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 12, 2024 | 10-Q | Quarterly Report |
Sep 27, 2024 | 4 | Filing |
Sep 27, 2024 | 8-K | Current Report |
Aug 27, 2024 | 8-K | Current Report |
Aug 14, 2024 | SC 13D/A | [Amend] Filing |
Aug 12, 2024 | 4 | Filing |
Aug 07, 2024 | 10-Q | Quarterly Report |
Aug 02, 2024 | 8-K | Current Report |
Jul 09, 2024 | DEFA14A | Filing |
Jul 08, 2024 | DEF 14A | Filing |